Lafayette Investments, Inc. Rani Therapeutics Holdings, Inc. Transaction History
Lafayette Investments, Inc.
- $482 Million
- Q2 2025
A detailed history of Lafayette Investments, Inc. transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Lafayette Investments, Inc. holds 19,893 shares of RANI stock, worth $9,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,893
Previous 19,893
-0.0%
Holding current value
$9,747
Previous $25,000
60.0%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
45Shares Held
6.28MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$1.54 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$391,8420.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$241,8560.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$148,3440.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$93,3720.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $12M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...